Symbols / AAPG Stock $22.75 -11.10% Ascentage Pharma Group Internat

Healthcare • Biotechnology • China • NGM
AAPG (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; APG-115, an oral small molecule inhibitor of the MDM2-p53 protein-protein interactions to treat solid tumors and hematological malignancies; and APG-1252, a small molecule drug to restore apoptosis through dual inhibition of the Bcl-2 and Bcl-xL proteins for the treatment of small-cell lung cancer, non-small cell lung cancer, neuroendocrine tumor, and non-Hodgkin's lymphoma. In addition, the company is developing APG-1387, a small-molecule inhibitor of apoptosis proteins for advanced solid tumors and chronic HBV infection; APG-2449, an oral inhibitor of FAK, ROS1, and ALK kinases; APG-5918, an orally available and selective embryonic ectoderm development inhibitor. In addition, it is involved in medical research and development; clinical development; clinical trials operations; venture capital investment; rental of buildings; and provision of science and technology promotion services. The company has collaboration relationships with biotechnology and pharmaceutical companies; and research institutions. Ascentage Pharma Group International was founded in 2009 and is headquartered in Suzhou, China.

Stock Fundamentals
Scroll to Statements
Market Cap 2.12B Enterprise Value 8.83B Income -1.24B Sales 574.12M Book/sh 2.09 Cash/sh 6.66
Dividend Yield — Payout 0.00% Employees 767 IPO — P/E — Forward P/E -19.04
PEG — P/S 3.70 P/B 10.86 P/C — EV/EBITDA -7.80 EV/Sales 15.39
Quick Ratio 1.66 Current Ratio 1.79 Debt/Eq 148.38 LT Debt/Eq — EPS (ttm) -2.05 EPS next Y -1.20
EPS Growth — Revenue Growth 117.00% Earnings 2026-03-25 ROA -23.02% ROE -154.56% ROIC —
Gross Margin 91.48% Oper. Margin -193.35% Profit Margin -216.47% Shs Outstand 93.33M Shs Float 283.95M Short Float 0.00%
Short Ratio 0.42 Short Interest — 52W High 48.45 52W Low 19.11 Beta 0.81 Avg Volume 2.79K
Volume 8.82K Target Price $49.00 Recom Strong_buy Prev Close $25.59 Price $22.75 Change -11.10%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$49.00
Mean price target
2. Current target
$22.75
Latest analyst target
3. DCF / Fair value
$49.00
Proxy: analyst mean price target (no FCF/EPS data available).
Ratings
Current target
$22.75
Low
$45.00
High
$55.00
Mean
$49.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-13 reit BTIG Buy → Buy $48
2026-03-26 reit BTIG Buy → Buy $48
2025-12-04 init Oppenheimer — → Outperform $45
2025-11-24 init Truist Securities — → Buy $51
2025-11-10 init BTIG — → Buy $50
2025-11-05 init Piper Sandler — → Overweight $48
2025-03-27 init JP Morgan — → Overweight —
News
RSS: Latest AAPG news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
980.65
+341.77%
221.98
+5.85%
209.71
+651.38%
27.91
Operating Revenue
980.65
+341.77%
221.98
+5.85%
209.71
+651.38%
27.91
Cost Of Revenue
29.09
-4.77%
30.54
+38.84%
22.00
+561.00%
3.33
Reconciled Cost Of Revenue
29.09
-4.77%
30.54
+38.84%
22.00
+561.00%
3.33
Gross Profit
951.57
+397.05%
191.44
+1.99%
187.71
+663.62%
24.58
Operating Expense
1,321.30
+24.17%
1,064.08
+2.56%
1,037.52
+16.00%
894.42
Research And Development
947.25
+33.99%
706.97
-4.86%
743.10
-3.05%
766.49
Selling General And Administration
383.12
+1.77%
376.46
+14.77%
328.02
+71.50%
191.26
Selling And Marketing Expense
196.00
+0.31%
195.39
+24.12%
157.42
+229.69%
47.75
General And Administrative Expense
187.12
+3.34%
181.08
+6.14%
170.59
+18.87%
143.51
Salaries And Wages
—
—
—
80.01
Other Gand A
187.12
+3.34%
181.08
+6.14%
170.59
+18.87%
143.51
Other Operating Expenses
-9.07
+53.13%
-19.36
+42.38%
-33.60
+46.95%
-63.34
Total Expenses
1,350.38
+23.37%
1,094.62
+3.31%
1,059.52
+18.02%
897.75
Operating Income
-369.73
+57.63%
-872.64
-2.69%
-849.81
+2.30%
-869.84
EBITDA
-237.63
+68.04%
-743.61
+3.61%
-771.47
+2.00%
-787.19
Normalized EBITDA
-243.44
+67.43%
-747.36
+4.25%
-780.51
+9.01%
-857.78
Reconciled Depreciation
93.17
-0.03%
93.19
+48.13%
62.91
+122.11%
28.33
EBIT
-330.80
+60.47%
-836.80
-0.29%
-834.39
-2.31%
-815.52
Total Unusual Items
5.81
+55.07%
3.75
-58.51%
9.03
-87.20%
70.59
Total Unusual Items Excluding Goodwill
5.81
+55.07%
3.75
-58.51%
9.03
-87.20%
70.59
Special Income Charges
-0.05
-1350.00%
0.00
-99.81%
2.07
+6182.35%
-0.03
Other Special Charges
—
-0.00
+99.81%
-2.07
-6182.35%
0.03
Net Income
-405.43
+56.20%
-925.64
-4.84%
-882.92
-12.84%
-782.42
Pretax Income
-395.25
+57.63%
-932.86
-5.15%
-887.17
-6.60%
-832.25
Net Non Operating Interest Income Expense
-26.61
+58.18%
-63.65
-47.82%
-43.06
-347.36%
-9.62
Interest Expense Non Operating
64.45
-32.90%
96.06
+81.98%
52.78
+215.49%
16.73
Net Interest Income
-26.61
+58.18%
-63.65
-47.82%
-43.06
-347.36%
-9.62
Interest Expense
64.45
-32.90%
96.06
+81.98%
52.78
+215.49%
16.73
Interest Income Non Operating
37.84
+16.76%
32.41
+233.19%
9.73
+36.88%
7.11
Interest Income
37.84
+16.76%
32.41
+233.19%
9.73
+36.88%
7.11
Other Income Expense
1.09
-68.15%
3.42
-39.92%
5.70
-87.94%
47.21
Other Non Operating Income Expenses
-4.44
-216.76%
-1.40
+54.18%
-3.06
+86.91%
-23.38
Gain On Sale Of Security
5.86
+56.57%
3.74
-46.25%
6.97
-90.14%
70.62
Tax Provision
10.43
+245.80%
-7.15
-68.31%
-4.25
+91.47%
-49.83
Tax Rate For Calcs
0.00
+3161.58%
0.00
+53.30%
0.00
-91.67%
0.00
Tax Effect Of Unusual Items
1.45
+4957.98%
0.03
-36.40%
0.05
-98.93%
4.24
Net Income Including Noncontrolling Interests
-405.68
+56.18%
-925.71
-4.85%
-882.92
-12.84%
-782.42
Net Income From Continuing Operation Net Minority Interest
-405.43
+56.20%
-925.64
-4.84%
-882.92
-12.84%
-782.42
Net Income From Continuing And Discontinued Operation
-405.43
+56.20%
-925.64
-4.84%
-882.92
-12.84%
-782.42
Net Income Continuous Operations
-405.68
+56.18%
-925.71
-4.85%
-882.92
-12.84%
-782.42
Minority Interests
0.25
+229.33%
0.07
0.00
—
Normalized Income
-409.79
+55.91%
-929.36
-4.20%
-891.91
-5.08%
-848.78
Net Income Common Stockholders
-405.43
+56.20%
-925.64
-4.84%
-882.92
-12.84%
-782.42
Otherunder Preferred Stock Dividend
—
0.00
0.00
0.00
Diluted EPS
-5.36
+59.15%
-13.12
+2.09%
-13.40
-9.12%
-12.28
Basic EPS
-5.36
+59.15%
-13.12
+2.09%
-13.40
-9.12%
-12.28
Basic Average Shares
75.52
+7.00%
70.57
+7.06%
65.92
+3.56%
63.65
Diluted Average Shares
75.52
+7.00%
70.57
+7.06%
65.92
+3.56%
63.65
Diluted NI Availto Com Stockholders
-405.43
+56.20%
-925.64
-4.84%
-882.92
-12.84%
-782.42
Depreciation Amortization Depletion Income Statement
—
—
—
13.37
Depreciation And Amortization In Income Statement
—
—
—
13.37
Depreciation Income Statement
—
—
—
13.37
Earnings From Equity Interest
-0.28
-126.12%
1.08
+487.05%
-0.28
0.00
Gain On Sale Of PPE
-0.05
-1350.00%
0.00
-99.81%
2.07
+6182.35%
-0.03
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
2,617.81
+4.70%
2,500.39
-11.66%
2,830.26
-3.73%
2,940.06
Current Assets
1,474.16
+9.67%
1,344.18
-17.86%
1,636.49
-13.20%
1,885.28
Cash Cash Equivalents And Short Term Investments
1,236.58
+15.64%
1,069.30
-27.54%
1,475.64
-13.55%
1,706.89
Cash And Cash Equivalents
1,236.58
+15.64%
1,069.30
-27.54%
1,475.64
-13.55%
1,706.89
Cash Equivalents
343.48
+999.20%
31.25
-75.96%
130.00
0.00
Cash Financial
893.10
-13.96%
1,038.05
-22.86%
1,345.64
-21.16%
1,706.89
Receivables
99.07
-39.42%
163.54
+165.97%
61.49
-19.57%
76.45
Accounts Receivable
83.14
-43.01%
145.89
+168.40%
54.36
+0.72%
53.97
Other Receivables
6.14
-7.53%
6.64
+922.65%
0.65
+308.18%
0.16
Taxes Receivable
9.79
-11.04%
11.01
+69.80%
6.48
-70.96%
22.32
Inventory
6.60
-59.19%
16.17
+71.12%
9.45
+140.41%
3.93
Work In Process
2.74
-46.24%
5.09
+1.01%
5.04
+134.54%
2.15
Finished Goods
3.86
-65.15%
11.08
+151.20%
4.41
+147.47%
1.78
Prepaid Assets
107.28
+51.87%
70.64
-3.65%
73.31
+20.03%
61.08
Restricted Cash
24.63
+0.39%
24.54
+47.80%
16.60
-55.05%
36.94
Total Non Current Assets
1,143.65
-1.09%
1,156.21
-3.15%
1,193.77
+13.18%
1,054.78
Net PPE
905.86
-5.37%
957.23
+47.26%
650.02
-23.91%
854.30
Gross PPE
1,127.30
+1.74%
1,108.06
+53.77%
720.60
-19.59%
896.19
Accumulated Depreciation
-221.44
-46.82%
-150.83
-113.72%
-70.58
-68.49%
-41.89
Properties
0.00
0.00
0.00
0.00
Land And Improvements
26.47
-4.09%
27.60
-3.93%
28.73
-3.78%
29.86
Buildings And Improvements
865.66
+0.83%
858.57
+75.89%
488.12
+15.01%
424.43
Machinery Furniture Equipment
183.34
+1.93%
179.87
+15.88%
155.21
+154.54%
60.98
Construction In Progress
7.59
-40.74%
12.81
-68.59%
40.79
-89.06%
372.79
Other Properties
—
—
648.72
+6430.32%
9.93
Leases
44.24
+51.41%
29.22
+277.44%
7.74
-4.84%
8.13
Goodwill And Other Intangible Assets
100.69
-8.58%
110.14
+1.05%
109.00
+28.07%
85.11
Goodwill
24.69
+0.00%
24.69
+0.00%
24.69
+0.00%
24.69
Other Intangible Assets
76.00
-11.06%
85.45
+1.35%
84.30
+39.55%
60.41
Investments And Advances
33.86
+78.68%
18.95
+2.26%
18.53
-33.45%
27.84
Long Term Equity Investment
32.72
+92.48%
17.00
+6.76%
15.92
-1.72%
16.20
Non Current Accounts Receivable
26.03
+269.17%
7.05
—
35.88
Non Current Deferred Assets
74.77
+24.94%
59.84
+10.22%
54.29
+5.12%
51.65
Non Current Deferred Taxes Assets
44.24
-26.08%
59.84
+10.22%
54.29
+5.12%
51.65
Non Current Prepaid Assets
2.44
-18.70%
3.00
-53.85%
6.50
0.00
Other Non Current Assets
—
—
7.80
-82.97%
45.81
Total Liabilities Net Minority Interest
2,343.65
-3.54%
2,429.76
+0.34%
2,421.60
+42.00%
1,705.32
Current Liabilities
1,166.61
+24.88%
934.17
+6.02%
881.15
+144.01%
361.11
Payables And Accrued Expenses
333.46
+19.37%
279.36
-16.76%
335.59
+26.62%
265.04
Payables
251.61
+8.79%
231.28
-22.83%
299.71
+18.67%
252.56
Accounts Payable
91.97
+26.95%
72.44
-24.19%
95.56
+34.85%
70.86
Other Payable
150.01
-0.28%
150.44
-23.62%
196.97
+10.39%
178.42
Current Accrued Expenses
81.86
+70.24%
48.08
+33.99%
35.88
+187.52%
12.48
Total Tax Payable
9.63
+14.76%
8.39
+16.85%
7.18
+118.94%
3.28
Current Debt And Capital Lease Obligation
779.06
+26.39%
616.40
+18.91%
518.38
+948.28%
49.45
Current Debt
769.62
+26.87%
606.65
+18.88%
510.31
+1182.17%
39.80
Other Current Borrowings
769.62
+26.87%
606.65
+18.88%
510.31
+1182.17%
39.80
Current Capital Lease Obligation
9.44
-3.26%
9.76
+20.78%
8.08
-16.30%
9.65
Current Deferred Liabilities
54.09
+40.81%
38.41
+57.72%
24.35
-0.02%
24.36
Current Deferred Revenue
54.09
+40.81%
38.41
+57.72%
24.35
-0.02%
24.36
Other Current Liabilities
—
—
2.82
-87.32%
22.26
Total Non Current Liabilities Net Minority Interest
1,177.04
-21.30%
1,495.59
-2.91%
1,540.45
+14.60%
1,344.21
Long Term Debt And Capital Lease Obligation
889.43
-24.57%
1,179.19
-7.47%
1,274.34
+23.14%
1,034.84
Long Term Debt
868.64
-25.52%
1,166.27
-7.82%
1,265.20
+23.24%
1,026.59
Long Term Capital Lease Obligation
20.79
+60.89%
12.92
+41.34%
9.14
+10.88%
8.25
Tradeand Other Payables Non Current
0.00
-100.00%
18.30
-48.21%
35.33
-32.50%
52.34
Non Current Deferred Liabilities
281.33
-5.63%
298.10
+29.17%
230.78
-10.22%
257.03
Non Current Deferred Revenue
275.96
-4.03%
287.55
+31.53%
218.62
-10.13%
243.28
Non Current Deferred Taxes Liabilities
5.37
-49.11%
10.55
-13.18%
12.15
-11.65%
13.75
Other Non Current Liabilities
6.27
—
—
—
Stockholders Equity
264.19
+337.28%
60.42
-85.22%
408.66
-66.90%
1,234.74
Common Stock Equity
264.19
+337.28%
60.42
-85.22%
408.66
-66.90%
1,234.74
Capital Stock
0.21
+8.63%
0.20
+9.44%
0.18
+1.12%
0.18
Common Stock
0.21
+8.63%
0.20
+9.44%
0.18
+1.12%
0.18
Share Issued
315.22
+8.62%
290.20
+9.43%
265.19
+0.88%
262.88
Ordinary Shares Number
315.22
+8.62%
290.20
+9.43%
265.19
+0.88%
262.88
Additional Paid In Capital
6,545.13
+9.98%
5,951.15
+10.35%
5,393.03
+0.95%
5,342.07
Retained Earnings
-5,770.56
-7.56%
-5,365.12
-20.85%
-4,439.48
-24.83%
-3,556.56
Gains Losses Not Affecting Retained Earnings
-510.59
-1.21%
-504.46
+2.71%
-518.51
+5.89%
-550.95
Treasury Stock
0.01
-99.96%
21.35
-19.59%
26.55
+884966.67%
0.00
Minority Interest
9.97
-2.42%
10.21
0.00
—
Other Equity Adjustments
-384.51
-3.52%
-371.44
-3.40%
-359.24
-8.80%
-330.17
Total Equity Gross Minority Interest
274.16
+288.16%
70.63
-82.72%
408.66
-66.90%
1,234.74
Total Capitalization
1,132.84
-7.65%
1,226.68
-26.72%
1,673.86
-25.98%
2,261.33
Working Capital
307.55
-24.99%
410.00
-45.72%
755.34
-50.44%
1,524.17
Invested Capital
1,902.46
+3.77%
1,833.33
-16.06%
2,184.16
-5.08%
2,301.13
Total Debt
1,668.50
-7.08%
1,795.60
+0.16%
1,792.73
+65.34%
1,084.29
Net Debt
401.69
-42.91%
703.62
+134.64%
299.87
—
Capital Lease Obligations
30.23
+33.29%
22.68
+31.70%
17.22
-3.78%
17.90
Net Tangible Assets
163.50
+428.83%
-49.72
-116.59%
299.66
-73.93%
1,149.63
Tangible Book Value
163.50
+428.83%
-49.72
-116.59%
299.66
-73.93%
1,149.63
Financial Assets Designatedas Fair Value Through Profitor Loss Total
1.14
-41.52%
1.95
-25.22%
2.61
-77.60%
11.64
Foreign Currency Translation Adjustments
-126.07
+5.22%
-133.02
+16.49%
-159.28
+27.85%
-220.78
Interest Payable
—
1.05
+173.11%
0.38
+3.79%
0.37
Investment Properties
—
0.00
-100.00%
355.43
0.00
Investmentin Financial Assets
1.14
-41.52%
1.95
-25.22%
2.61
-77.60%
11.64
Investmentsin Joint Venturesat Cost
32.72
+92.48%
17.00
+6.76%
15.92
-1.72%
16.20
Line Of Credit
—
—
—
0.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-111.36
+84.66%
-726.08
-11.04%
-653.91
-8.14%
-604.68
Cash Flow From Continuing Operating Activities
-111.36
+84.66%
-726.08
-11.04%
-653.91
-8.14%
-604.68
Net Income From Continuing Operations
-395.25
+57.63%
-932.86
-5.15%
-887.17
-6.60%
-832.25
Depreciation Amortization Depletion
93.17
-0.03%
93.19
+48.13%
62.91
+122.11%
28.33
Depreciation
82.32
-0.58%
82.80
+55.83%
53.13
+151.60%
21.12
Amortization Cash Flow
10.85
+4.35%
10.40
+6.31%
9.78
+35.71%
7.21
Depreciation And Amortization
93.17
-0.03%
93.19
+48.13%
62.91
+122.11%
28.33
Amortization Of Intangibles
10.85
+4.35%
10.40
+6.31%
9.78
+35.71%
7.21
Other Non Cash Items
64.37
-32.99%
96.06
+82.69%
52.58
+51.76%
34.65
Stock Based Compensation
20.92
-33.58%
31.50
+42.52%
22.11
-52.94%
46.97
Operating Gains Losses
-6.36
-15.21%
-5.52
+70.18%
-18.52
+80.51%
-95.04
Gain Loss On Investment Securities
—
-2.82
+85.48%
-19.43
+77.81%
-87.57
Unrealized Gain Loss On Investment Securities
0.83
+19.03%
0.70
-92.84%
9.77
-63.64%
26.86
Net Foreign Currency Exchange Gain Loss
-6.69
-312.95%
-1.62
-159.97%
2.70
+136.02%
-7.50
Gain Loss On Sale Of PPE
0.05
+1350.00%
-0.00
+99.81%
-2.07
-6182.35%
0.03
Change In Working Capital
110.97
+1313.27%
-9.15
-108.76%
104.41
-44.95%
189.65
Change In Receivables
62.75
+168.55%
-91.54
-23492.01%
-0.39
+99.28%
-53.97
Changes In Account Receivables
62.75
+168.55%
-91.54
-23492.01%
-0.39
+99.28%
-53.97
Change In Inventory
9.57
+242.43%
-6.72
-21.77%
-5.52
-40.41%
-3.93
Change In Prepaid Assets
-14.42
-83.92%
-7.84
-351.56%
3.12
+117.63%
-17.68
Change In Payables And Accrued Expense
98.03
+285.04%
25.46
-69.01%
82.15
+25.66%
65.37
Change In Payable
98.03
+285.04%
25.46
-69.01%
82.15
+25.66%
65.37
Change In Account Payable
19.52
+184.46%
-23.11
-193.59%
24.70
-48.00%
47.50
Change In Other Working Capital
3.99
-94.68%
75.04
+1835.52%
-4.32
-102.22%
194.87
Change In Other Current Assets
-48.95
-1278.10%
-3.55
-112.09%
29.38
+95.29%
15.04
Change In Other Current Liabilities
—
—
0.00
+100.00%
-10.06
Investing Cash Flow
-362.04
-1751.47%
21.92
+105.70%
-384.61
+17.56%
-466.52
Cash Flow From Continuing Investing Activities
-362.04
-1751.47%
21.92
+105.70%
-384.61
+17.56%
-466.52
Net PPE Purchase And Sale
-24.29
+47.31%
-46.09
+77.06%
-200.94
+53.82%
-435.08
Purchase Of PPE
-24.29
+47.32%
-46.11
+77.32%
-203.29
+53.31%
-435.42
Sale Of PPE
0.00
-100.00%
0.01
-99.40%
2.35
+601.79%
0.34
Capital Expenditure
-24.29
+57.27%
-56.84
+76.01%
-236.96
+45.73%
-436.63
Net Investment Purchase And Sale
-312.23
-416.18%
98.75
+175.96%
-130.00
-2276.83%
5.97
Purchase Of Investment
—
—
-130.00
+92.71%
-1,783.82
Sale Of Investment
—
—
0.00
-100.00%
1,789.79
Net Business Purchase And Sale
-25.52
-27.58%
-20.00
+0.00%
-20.00
+44.75%
-36.20
Purchase Of Business
-25.52
-27.58%
-20.00
+0.00%
-20.00
+44.75%
-36.20
Net Intangibles Purchase And Sale
0.00
+100.00%
-10.74
+68.12%
-33.67
-2673.89%
-1.21
Purchase Of Intangibles
0.00
+100.00%
-10.74
+68.12%
-33.67
-2673.89%
-1.21
Financing Cash Flow
314.77
-14.64%
368.75
-40.45%
619.27
-65.24%
1,781.39
Cash Flow From Continuing Financing Activities
314.77
-14.64%
368.75
-40.45%
619.27
-65.24%
1,781.39
Net Issuance Payments Of Debt
-145.34
-988.12%
-13.36
-101.92%
695.87
+28.99%
539.50
Issuance Of Debt
535.92
-43.79%
953.50
+24.87%
763.62
+27.33%
599.74
Repayment Of Debt
-681.26
+29.54%
-966.86
-1327.24%
-67.74
-12.45%
-60.24
Long Term Debt Issuance
535.92
-43.79%
953.50
+24.87%
763.62
+27.33%
599.74
Long Term Debt Payments
-681.26
+29.54%
-966.86
-1327.24%
-67.74
-12.45%
-60.24
Net Long Term Debt Issuance
-145.34
-988.12%
-13.36
-101.92%
695.87
+28.99%
539.50
Net Common Stock Issuance
533.94
+15.03%
464.16
+1833.49%
-26.78
-102.29%
1,170.90
Common Stock Payments
0.00
+100.00%
-5.92
+77.88%
-26.78
-3.49%
-25.87
Cash Dividends Paid
0.00
0.00
0.00
0.00
Repurchase Of Capital Stock
0.00
+100.00%
-5.92
+77.88%
-26.78
-3.49%
-25.87
Proceeds From Stock Option Exercised
0.01
-25.00%
0.01
-57.89%
0.02
-99.98%
103.87
Net Other Financing Charges
-13.28
-229.09%
10.29
—
-16.07
Changes In Cash
-158.62
+52.71%
-335.40
+20.00%
-419.26
-159.04%
710.19
Effect Of Exchange Rate Changes
13.68
-50.83%
27.81
-52.06%
58.01
+349.20%
-23.28
Beginning Cash Position
1,038.05
-22.86%
1,345.64
-21.16%
1,706.89
+67.35%
1,019.98
End Cash Position
893.10
-13.96%
1,038.05
-22.86%
1,345.64
-21.16%
1,706.89
Free Cash Flow
-135.65
+82.67%
-782.92
+12.12%
-890.88
+14.45%
-1,041.31
Common Stock Issuance
533.94
+13.58%
470.08
0.00
-100.00%
1,196.77
Earnings Losses From Equity Investments
0.28
+126.12%
-1.08
-487.05%
0.28
0.00
Interest Paid CFF
-60.56
+34.43%
-92.35
-85.26%
-49.85
-196.58%
-16.81
Issuance Of Capital Stock
533.94
+13.58%
470.08
0.00
-100.00%
1,196.77
Taxes Refund Paid
—
—
0.00
+100.00%
-3.85
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category